Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and ...
Texas Facility Expansion Increases Magnet Capacity, Supports Domestic Critical-Minerals Supply Chains and Increases Post-Tax NPV to US$780 million (forecast prices) and US$409 million (current prices) ...
US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
Dyne’s exon-skipping therapy zeleciment rostudirsen resulted in an approximately sevenfold increase in dystrophin levels at ...
The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new ...
FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading ...
Igyxos Biotherapeutics is dedicated to developing innovative treatments for infertility in both men and women. Its lead asset, IGX12, is a first-in-class potentiating monoclonal antibody designed to ...
The release of Phase III Stage 1 data for gotistobart (BNT316/ONC-392) at NACLC 2025 marks one of the most significant ...
12don MSN
Unintended competitors: Why L.A. preschools are closing as transitional kindergarten thrives
L.A. County's local preschools are closing in areas where transitional kindergarten is thriving, disrupting an already ...
Child care centers that also served infants and toddlers became harder to keep open when 4-year-olds went to transitional ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback